¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"insulin convulsive therapy combined"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® Electric convulsive therapy(ECT) ÇÑ±Û Àü±â°æ·Ã¿ä¹ý
¼³¸í   
  ³ú¿¡ Àü±â ÀÚ±ØÀ» ÁÖ¾î ÀÎÀ§ÀûÀ¸·Î °æ·ÃÀ» À¯¹ßÇÔÀ¸·Î½á Á¤½Å º´À» Ä¡·áÇϴ ¹æ¹ý. Àü±â¼îÅ©¿ä¹ý(electroshock therapy)À̶ó°íµµ ÇÑ´Ù. 1938³â¿¡ ÀÌÅ»¸®¾ÆÀǠü¸¦·¹Æ¼¿Í ºñ´Ï¿¡ ÀÇÇØ ½ÃÀ۵Ǿú´Ù. ÀÛ¿ë±âÀüÀº È®½ÇÄ¡ ¾ÊÀ¸³ª ³úÀÇ ½ÅÁø´ë»ç, »ýÈ­ÇР¹× È¿¼Ò µî¿¡ º¯È­¸¦ ÀÏÀ¸Å²´Ù´Â »ý¹°ÇÐÀû, »ýÈ­ÇÐÀû Çм³ÀÌ À¯·ÂÇÏ´Ù.
  
  ÀûÀÀÁõÀ¸·Î °¡Àå È¿°úÀûÀΠº´Àº ¿ì¿ïÁõÀ¸·Î Æ¯È÷ ¿©¼º¿¡¼­ °»³â±â¿¡ È£¹ßÇϴ °»³â±â ¿ì¿ïÁõ, ¿ì¿ïÁõ°ú Á¶Áõ(¾ÆÁÖ ±âºÐÀÌ ÁÁÀº »óŰ¡ Áö¼ÓµÇ´Â Á¤½Åº´)ÀÌ ÀÏÁ¤ÇÑ Áֱ⸦ µÎ°í ¹Ýº¹Çϴ Á¶¿ïÁõ¿¡ Àß ¾²À̸ç, 80~90%¿¡¼­ È¿°ú°¡ ÀÖ´Ù.
¿µ¹® insulin ÇÑ±Û Àν¶¸°
¼³¸í   
  ÀÌÀÚ ¶û°ÖÇѽº¼¶ÀÇ B¼¼Æ÷°¡ ÇÕ¼º-ºÐºñÇϴ ȣ¸£¸ó ´Ü¹éÁú, Æ÷µµ´çÀ» ±Û¸®ÄÚ°ÕÀ¸·Î ¹Ù²Ù´Â È£¸£¸ó´Ü¹éÁú·Î, ºÐÀÚ·®Àº 5,807ÀÌ´Ù. Ç÷ÁßÀÇ ´ç³óµµ »ó½ÂÀ¸·Î ÀÎÇÏ¿© ºÐºñ°¡ ÃËÁøµÈ´Ù. ±ÙÀ°-Áö¹æÁ¶Á÷-°£ µî Ç¥Àû¼¼Æ÷ÀÇ ¼ö¿ëü ´Ü¹éÁú°ú °áÇÕÇÏ¿© Á¤º¸¸¦ ¼¼Æ÷³»·Î Àü´ÞÇÔÀ¸·Î½á Ç÷¾× Áß¿¡¼­ ´ç, ÁöÁú, ¾Æ¹Ì³ë»ê ´ë»ç¸¦ Á¶ÀýÇÑ´Ù. ´çÀÇ Á¶Á÷¿¡ ¹Þ¾Æµå¸®´Â °ÍÀ» ÃËÁøÇÏ¿© Ç÷´çÀ» ÀúÇϽÃŲ´Ù. »ý¼º-ºÐºñ·® ÀúÇÏ, Á¶Á÷¼¼Æ÷ÀÇ ¼ö¿ëü ºÎÁ·Àº °íÇ÷´çÀÇ ¿øÀÎÀÌ µÈ´Ù. ¶ÇÇÑ ¾Æ¹Ì³ë»êÀÇ Èí¼ö¿Í ´Ü¹éÁú, Áö¹æÀÇ ÇÕ¼ºÀ» ÃËÁøÇϸç Áö¹æºÐÇØ´Â ¾ïÁ¦ÇÑ´Ù. Àν¶¸°Àº ÀÌÀÚȰ¼º¼ººÐÀÇ ¾àǰÀ¸·Î¼­ ´ç´¢º´ ¹× ±âŸ ÁúȯÀÇ Ä¡·á¿¡ »ç¿ëµÈ´Ù. Àν¶¸°À̶ó´Â ¸íĪÀº ¼¶À̶õ ¶æÀÇ ¶óƾ¾îÀΠinsula¿¡¼­ ¿¬À¯ÇÑ´Ù. 1921³â Ä³³ª´ÙÀÇ ÀÇ»ç F.G. ¹êÆÃ°ú C.H. º£½ºÆ®¿¡ ÀÇÇÏ¿© Ã³À½À¸·Î ÀÌÀÚ¿¡¼­ Ã¤ÃëµÇ¾ú°í, ±× ÈÄ Àν¶¸°ÀÇ °áÁ¤À» ¾ò°Ô µÇ¾ú´Ù. F. »ý°Å¿¡ ÀÇÇØ¼­ ¼ÒÀÇ Àν¶¸°ÀÇ ±¸Á¶°¡ ¹àÇôÁ³´Âµ¥(1955), À̰ÍÀº ´Ü¹éÁú Áß¿¡¼­´Â ÃÖÃʷΠ±¸Á¶½ÄÀÌ ¹àÇôÁø °ÍÀÌ´Ù. Æ÷µµ´çÀ¸·ÎºÎÅÍ ±Û¸®ÄÚ°ÕÀÇ »ý¼º, Æ÷µµ´çÀÇ »êÈ­ ¹× Áö¹æÀ¸·ÎÀÇ ÀüÈ­ µîÀ» ÃËÁøÇϴ ÀÛ¿ëÀÌ ÀÖ´Ù. µû¶ó¼­ Àν¶¸°ÀÇ ¼ö¿ë¾×À» ÁÖ»çÇϸé Ç÷´çÀÌ ÀúÇÏÇϹǷΠ´ç´¢º´ÀÇ Ä¡·á¿¡ ¾²ÀδÙ. ¶Ç Àν¶¸°À» ÇÇÇÏ¿¡ ´ë·® ÁÖ»çÇϸé È¥¼ö¿¡ ºüÁö´Â °ÍÀ» ÀÌ¿ëÇÏ¿© Á¤½Åº´ Ä¡·á¿¡ Àν¶¸°¼îÅ©¿ä¹ýÀ¸·Î¼­ ¾²ÀδÙ.
  
  
¿µ¹® IDDM(Insulin-Dependent Diabetes Mellitus) ÇÑ±Û Àν¶¸°ÀÇÁ¸´ç´¢º´
¼³¸í   
  IDDMÀº ´ç´¢º´ÀÇ Ä¡·á¿¡ ¹Ýµå½Ã Àν¶¸°ÀÌ ÇÊ¿äÇÑ °æ¿ì¸¦ ¸»ÇÑ´Ù. ÁַΠ¿øÀÎÀÌ ÀÌÀÚ¿¡ Àִ Àν¶¸°À» ºÐºñÇϴ ¼¼Æ÷ÀÇ ÆÄ±«À̸ç À̷ΠÀÎÇØ¼­ ´ç´¢º´ÀÇ Ä¡·áÁ¦·Î ¾²À̴ Àν¶¸°ÀÇ ºÐºñ¸¦ ÃËÁøÇϴ ¾à¹°ÀÌ ÀÌ IDDM¿¡¼­´Â ¾²ÀÏ ¼ö°¡ ¾ø°í ¿ÀÁ÷ Àν¶¸°¸¸ÀÌ Ä¡·áÁ¦·Î ¾µ ¼ö°¡ ÀÖ´Ù. ÀüÇüÀûÀΠÀν¶¸° ÀÇÁ¸Çü ´ç´¢º´Àº ¼Ò¾Æ¿¡¼­ ÈçÈ÷ ¹ß»ýÇϰí Àν¶¸° ºÐºñ¼¼Æ÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼­ Àν¶¸° ºÐºñ´ÉÀº °ÅÀÇ ¾ø´Ù.
¿µ¹® family therapy ÇÑ±Û °¡Á·¿ä¹ý
¼³¸í   
  °¡Á·À» Ä¡·á ´ë»óÀ¸·Î Çϴ ½É¸®¿ä¹ý ÁßÀÇ Çϳª. °¡Á·ÁßÀÇ ¹®Á¦´Â ¹®Á¦¸¦ °¡Áø °³Àθ¸ÀÌ ¾Æ´Ï¶ó ¹®Á¦ °¡Á·À» ´ë»óÀ¸·Î ÇذáÇØ ³ª°¥ Çʿ䰡 Àִٴ ÀνÄÀ» ¹ÙÅÁÀ¸·Î ÇÏ¿© °¡Á· ÀüüÀÇ ½É¸®Àû ¼º¼÷À» ¸ñÇ¥·Î ÇÑ ¿ä¹ýÀÌ´Ù. Å©°Ô ³ª´©¾î °¡Á· ÁßÀǠƯÁ¤ÀÎÀ» ´ë»óÀ¸·Î ÇÏ¿© °¢°¢ ´Ù¸¥ µ¶¸³µÈ Ä¡·á¸¦ Çϴ º´Çà½É¸®¿ä¹ý°ú °¡Á· Àüü¸¦ µ¿½Ã ¸éÁ¢Çϴ ¹æ¹ýÀ» ÁַΠÇϴ ÇÕµ¿°¡Á·¿ä¹ýÀÌ Àִµ¥, Æ¯È÷ ÈÄÀÚ¸¦ °¡¸®ÄÑ °¡Á·¿ä¹ý À̶ó°í Çϴ °æ¿ì°¡ ¸¹´Ù.
¿µ¹® intracavitary therapy ÇÑ±Û °­³»¿ä¹ý
¼³¸í   
  Ã¼°­³», Áï ÀÔ¾È, ÄÚ¾È, Àεΰ­, ½Äµµ, °ðâÀÚ, Áú, Àڱøñ, ¹æ±¤ µîÀÇ ³»°­¿¡, ¶§·Î´Â º´ÅÍ¿¡ ÀÇÇØ »ý±ä °øµ¿³»¿¡ ¹æ»ç¼±À» »ðÀÔÇØ¼­ Ä¡·áÇϴ °ÍÀ» ¸»ÇÑ´Ù. ÁַΠÁ¾¾çÀÇ Ä¡·á¸¦ ¸ñÀûÀ¸·Î ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • combined modality therapy
    º´¿ë¿ä¹ý
  • convulsive
    1. °æ·Ã- 2. °æ·ÃÀ¯¹ß-
  • convulsive laughter
    °æ·Ã¿ôÀ½
  • convulsive seizure
    °æ·Ã¹ßÀÛ
  • convulsive tic
    °æ·Ãƽ
  • focal convulsive seizure
    ÃÊÁ¡°æ·Ã¹ßÀÛ
  • combined anesthesia
    º´¿ë¸¶Ãë
  • combined aphasia
    º¹ÇÕ¾ð¾î»ó½ÇÁõ, º¹ÇսǾîÁõ
  • combined effect
    º´¿ëÈ¿°ú
  • combined examination
    µÎ¼ÕÁøÂû, ³»Áø
  • combined hyperlipidemia
    º¹ÇÕ°íÁöÁúÇ÷Áõ
  • combined immunodeficiency
    º¹Çո鿪°áÇÌ
  • combined immunodeficiency disease
    º¹Çո鿪°áÇ̺´
  • combined immunodeficiency syndrome
    º¹Çո鿪°áÇÌÁõÈıº
  • combined impression
    ¿¬ÇÕÀλó
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • convulsive tic
    °æ·Ãƽ
  • insulin
    Àν¶¸°
  • NPH insulin
    ¿£ÇÇ¿¡ÀÌÄ¡Àν¶¸°
  • regular insulin
    ¼ÓÈ¿Àν¶¸°, ºü¸¥ÀÛ¿ëÀν¶¸°
  • insulin resistance
    Àν¶¸°ÀúÇ×
  • therapy
    ¿ä¹ý
  • acetylsalycylic acid antiplatelet therapy
    Ç×Ç÷¼ÒÆÇ¿ä¹ý
  • adjuvant therapy
    º¸Á¶¿ä¹ý
  • antibiotic therapy
    Ç×»ýÁ¦¿ä¹ý
  • ASA antiplatelet therapy
    (¢¡acetylsalycylic acid antiplatelet therapy) Ç×Ç÷¼ÒÆÇ¿ä¹ý
  • behavioral therapy
    Çൿ¿ä¹ý
  • electroconvulsive therapy
    Àü±â°æ·Ã¿ä¹ý
  • estrogen replacement therapy
    ¿©¼ºÈ£¸£¸ó´ëü¿ä¹ý
  • gene therapy
    À¯ÀüÀÚ¿ä¹ý
  • home oxygen therapy
    °¡Á¤»ê¼Ò¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • convulsive shock therapy
    °æ·ÃÃæ°Ý¿ä¹ý
  • combined modality therapy
    º´¿ë¿ä¹ý
  • convulsive
    °æ·Ã¼º-, °æ·Ã¼ºÀå¾Ö
  • convulsive laughter
    °æ·Ã¿ôÀ½
  • convulsive seizure
    °æ·Ã¹ßÀÛ
  • convulsive tic
    °æ·Ãƽ
  • focal convulsive seizure
    ÃÊÁ¡°æ·Ã¹ßÀÛ
  • crystalline insulin
    °áÁ¤Àν¶¸°
  • depot insulin
    ÀúÀåÀν¶¸°
  • insulin-dependent diabetes
    Àν¶¸°ÀÇÁ¸´ç´¢º´
  • insulin-resistant diabetes
    Àν¶¸°ÀúÇ×´ç´¢º´
  • non-insulin-dependent diabetes
    ºñÀν¶¸°ÀÇÁ¸´ç´¢º´
  • insulin-like growth factor
    Àν¶¸°À¯»ç¼ºÀåÀÎÀÚ
  • glucose insulin tolerance test
    Æ÷µµ´çÀν¶¸°°ßµõ°Ë»ç
  • insulin-induced hypoglycemia
    Àν¶¸°À¯µµÀúÇ÷´ç(Áõ)
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • SCID= Severe combined mmunodeficiency
    ÁßÁõÈ¥Çո鿪°áÇÌÁõ.
  • immunodeficiency syndrome, severe combined
    ÁßÁõº¹ÇÕÇü ¸é¿ª°áÇÌ ÁõÈıº
  • insulin shock therapy
    Àν¶¸°¼ï¿ä¹ý.
  • insulin therapy
    Àν¶¸°Ä¡·á, Àν¶¸°¿ä¹ý.
  • IGF-I(insulin-like growth factor-I)
    Àν¶¸° À¯»ç ¼ºÀåÀÎÀÚ-1
  • Insulin
    Àν¶¸°
  • Insulin shock
    Àν¶¸°¼ï
  • Insulin-like growth factors
    Àν¶¸°¾ç(å×)¼ºÀå(à÷íþ)È£¸£¸ó
  • anti-insulin
    Ç×Àν¶¸°.
  • arginine-insulin test
    ¾Æ¸£±â´Ñ-Àν¶¸°½ÃÇè
  • globin insulin
    ±Û·ÎºóÀν¶¸°.
  • glucose insulin tolerance test =GITT
    Æ÷µµ´çÀν¶¸°ºÎÇϽÃÇè.
  • high purified insulin
    °í¼ø¼öÀν¶¸°.
  • immunoreactive insulin =IRI
    ¸é¿ª¹ÝÀÀ¼º(¡­Úãëëàõ) Àν¶¸°.
  • insulin receptor
    Àν¶¸°¼ö¿ëü(áôé»ô÷).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • insulin convulsive therapy combined
    Àν¶¸°°æ·Ãº´ÇÕÄ¡·á<¿ä¹ý>
  • insulin convulsive therapy combined
    Àν¶¸°°æ·Ãº´ÇÕÄ¡·á<¿ä¹ý>.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • convulsive shock therapy
    °æ·ÃÃæ°Ý¿ä¹ý(ÌâÕýõú̪èþÛö).
  • convulsive shock therapy =CST
    °æ·Ã¼ï¿ä¹ý(¡­èþÛö).
  • combined modality therapy
    º´¿ëÄ¡·á¹ý
  • insulin coma therapy
    Àν¶¸° È¥¼ö Ä¡·á
  • insulin shock therapy
    Àν¶¸°¼ï¿ä¹ý.
  • insulin therapy
    Àν¶¸°Ä¡·á, Àν¶¸°¿ä¹ý.
  • aura to convulsive state
    °æ·Ã»óÅÂÀüÁ¶.
  • convulsive disorder
    °æ·Ã¼º Àå¾Ö(ÌâÕýàõ î¡äô).
  • convulsive disorder
    °æ·Ã¼º Àå¾Ö(¡­î¡äô).
  • convulsive laughter
    °æ¼Ò(ÌâáÅ).
  • convulsive laughter
    °æ·Ã¼º(ÌâÕýàõ) ¿ôÀ½.
  • convulsive seizure
    °æ·Ã¹ßÀÛ(¡­Û¡íÂ).
  • convulsive seizure
    °æ·Ã¼º¹ßÀÛ(ÌâÕýàõÛ¡íÂ).
  • convulsive tic
    °æ·Ã¼º(ÌâÕýàõ)ƽ.
  • convulsive tic
    °æ·Ã¼º ƽ, ¾È¸é½Å°æ°æ·Ã(äÔØüãêÌèÌâÕý).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Beta cell [Insulin cell]
    º£Å¸¼¼Æ÷ [Àν´¸°¼¼Æ÷]
    [¿¾ ¿ë¾î] º£Å¸¼¼Æ÷
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • malarial therapy
    ¸»¶ó¸®¾Æ¿ä¹ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • combined acidity
    º¹Çջ굵(ÜÜùê߫Ӹ)
  • antidotal therapy
    Ç×ÇØµ¶Ä¡·á(ù÷ú°Ô¸ö½Öû)
  • enzyme replacement therapy
    È¿¼Ò ´ëü Ä¡·á (ý£áÈÓÛôðö½Öû)
  • enzyme therapy
    È¿¼ÒÄ¡·á (ý£áÈö½Öû)
  • gene therapy
    À¯ÀüÀÚ Ä¡·á(ë¶îîí­ö½Öû)
  • anti-insulin
    Ç×(ù÷)Àν¶¸°
  • atypical insulin
    ºñÁ¤Çü (ÞªïÒúþ)Àν¶¸°
  • bound insulin
    °áÇÕ(Ì¿ùê)Àν¶¸°
  • desalanine insulin
    ¾Ë¶ó´ÑÁ¦°Å(ð¶ËÛ)Àν¶¸°
  • free insulin
    À¯¸®(ë´×î) Àν¶¸°
  • globin zinc insulin
    ±Û·Îºó ¾Æ¿¬(䬿ç)Àν¶¸°
  • immunoreactive insulin
    ¸é¿ª¹ÝÀÀ¼º(Øóæ¹Úãëëàõ) Àν¶¸°
  • insulin
    Àν¶¸°
  • insulin resistance index
    Àν¶¸° ÀúÇ×Áö¼ö(î½ù÷ò¦â¦)
  • insulin shock
    Àν¶¸° ¼ï
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • convulsive disorder
    °æ·Ã¼ºÀå¾Ö
  • convulsive seizure
    °æ·Ã¹ßÀÛ
  • insulin
    Àν¶¸°
  • insulin dependent diabetes mellitus
    Àν¶¸°ÀÇÁ¸¼º´ç´¢º´
  • adjuvant therapy
    º¸Á¶¿ä¹ý
  • isotope therapy
    µ¿À§¿ø¼ÒÄ¡·á
  • maintenance therapy
    À¯Áö¿ë¹ý
  • percutaneous ethanol injection therapy
    °æÇÇÀû¿¡Å¸³îÁÖÀÔ¿ä¹ý
  • radiation therapy
    ¹æ»ç¼±Ä¡·á
  • radium therapy
    ¶óµãÄ¡·á
  • replacement therapy
    º¸»ó¿ä¹ý, ´ëÄ¡¿ä¹ý
  • therapy
    Ä¡·á, ¿ä¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CT calcitonin; calf testis; cardiac tamponade; cardiothoracic [ratio]; carotid tracing; carpal tunnel; ...
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
IT immunological test; immunotherapy; implantation test; individual therapy; information technology; in...
MT magnetization transfer; malaria therapy; malignant teratoma; mammary tumor; mammilothalamic tract; m...
ECT(?) Electro-Convulsive Therapy; Àü±â °æ·Ã ¿ä¹ý
  = EST
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECT Electro Convulsive Therapy
CMT combined modality therapy
ECT Electro-convulsive treatment
GCSE Generalised convulsive status epilepticus
NCSE Non convulsive status epilepticus
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • insulin convulsive therapy combined
    Àν¶¸° °æ·Ã º´ÇÕ Ä¡·á, Àν¶¸° °æ·Ã º´ÇÕ ¿ä¹ý
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • IGF-I : insulin like growth factor-IÀÇ ¾àÀÚ. ¼ºÀåÆÇÀÎ epiphyseal plate¿¡ ¿¬°ñ »ý¼ºÀ» Áõ°¡½ÃÄÑ »ÀÀÇ ¼ºÀåÀ» ÃËÁøÇÑ´Ù.

    IGF-II : insulin like growth factor-IIÀÇ ¾àÀÚ. ¸¹Àº Àå±â¿Í Á¶Á÷¿¡ ÀÛ¿ëÇÏ¿© ´Ü¹é ÇÕ¼º°ú DNA, RNAÀÇ ÇÕ¼ºÀ» Áõ°¡½ÃÄÑ ¼¼Æ÷ÀÇ ¼ö¿Í ¾çÀ» Áõ°¡

    Àν¶¸°¾ç ¼ºÀå ÀÎÀÚ °áÇÕ ´Ü¹éÁú
    insulinelike growth factor binding
  • convulsive shock therapy
    °æ·Ã ¼ï ¿ä¹ý
  • convulsive
    °æ·Ã¼ºÀÇ
  • convulsive reflex
    °æ·Ã ¹Ý»ç
    °³°³ÀÇ ±ÙÀ°µéÀÌ Çùµ¿ÇÏÁö ¾Ê°í µû·Îµû·Î °æ·Ã ¼öÃàÇÏ´Â °Í.
  • arginine-insulin test
    ¾Æ¸£±â´Ñ-Àν¶¸° ½ÃÇè
  • depot insulin
    ÀúÀå Àν½¸°
  • insulin dependent diabetes mellitus
    Àν¶¸° ÀÇÁ¸¼º ´ç´¢º´
  • insulin zinc suspension
    Àν¶¸° ¾Æ¿¬ Çöʾ×
  • lente insulin
    ·»Å× Àν¶¸°
  • monocomponent insulin
    ´Ü ¼ººÐ Àν¶¸°, ´ÜÀÏ ¼ººÐ Àν¶¸°
  • protamin insulin
    ÇÁ·ÎŸ¹Î Àν¶¸°
  • protamin zinc insulin
    ÇÁ·ÎŸ¹Î ¾Æ¿¬
  • short acting insulin
    ¼ÓÈ¿¼º Àν¶¸°
  • zinc insulin crystals
    ¾Æ¿¬ Àν¶¸° °áÁ¤
  • combined aphasia
    ÇÕº´¼º ½Ç¾î
    µ¿ÀÏÇÑ »ç¶÷¿¡°Ô µ¿½Ã¿¡ ÀϾ´Â µÎ °¡Áö ÇüÅ ÀÌ»óÀÇ ½Ç¾îÁõ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
convulsive therapy The use of convulsive agents to influence favourably the course of a mental disorder. It is used primarily in the treatment of severe affective disorders and schizophrenia.
(12 Dec 1998)
combined modality therapy <oncology> Two or more types of treatments used to supplement each other.
For instance, surgery, radiation, chemotherapy, hormonal or immunotherapy may be used alternatively or together for maximum effectiveness.
(09 Oct 1997)
convulsive Relating to convulsions; marked by or producing convulsions.
(05 Mar 2000)
convulsive reflex An incoordinated reflex in which muscles, even those opposing one another as in strychnine poisoning, contract.
(05 Mar 2000)
convulsive seizure Seizure with clonic or tonic-clonic motor activity.
(05 Mar 2000)
convulsive state <disease, neurology> The paroxysmal transient disturbances of brain function that may be manifested as episodic impairment or loss of consciousness, abnormal motor phenomena, psychic or sensory disturbances or perturbation of the autonomic nervous system.
Symptoms are due to paroxysmal disturbance of the electrical activity of the brain. On the basis of origin, epilepsy is idiopathic (cryptogenic, essential, genetic) or symptomatic (acquired, organic). On the basis of clinical and electroencephalographic phenomenon, four subdivisions are recognised:
1. Grand mal epilepsy (major epilepsy, haut mal epilepsy) subgroups: generalised, focal (localised), jacksonian (rolandic)
2. Petit mal epilepsy
3. Psychomotor epilepsy (temporal lobe epilepsy, psychic, psychic equivalent or variant) subgroups: psychomotor proper (tonic with adversive or torsion movements or masticatory phenomena), automatic (with amnesia) and sensory (hallucinations or dream states or d‚j. Vu)
4. Autonomic epilepsy (diencephalic), with flushing, pallor, tachycardia, hypertension, perspiration or other visceral symptoms.
Synonym: epilepsia.
Origin: Gr. Epilepsia = seizure
(14 May 1997)
convulsive tic Involuntary twitching of the facial muscles, sometimes unilateral.
Synonym: Bell's spasm, convulsive tic, facial spasm, histrionic spasm, mimic convulsion, mimic spasm, mimic tic, palmus, prosopospasm.
(05 Mar 2000)
anaesthetics, combined The use of two or more chemicals simultaneously or sequentially to induce anaesthesia. The drugs need not be in the same dosage form.
(12 Dec 1998)
antibiotics, combined Combination of antibiotics used against difficult-to-treat infections. Antibiotic combinations have been used mainly to broaden the antibacterial spectrum and prevent development of resistance. In some instances these combinations have shown lower toxicity, but drug antagonism may be one of the problems encountered by their use. They may be given simultaneously or sequentially. The drugs need not be in the same dosage form.
(12 Dec 1998)
antineoplastic agent, combined The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.
(12 Dec 1998)
vaccines, combined Two or more vaccines in a single dosage form.
(12 Dec 1998)
combined cycle Two or more generation processes in series or in parallel, configured to optimise the energy output of the system.
(05 Dec 1998)
combined-cycle power plant The combination of a gas turbine and a steam turbine in an electric generation plant. The waste heat from the gas turbine provides the heat energy for the steam turbine.
(05 Dec 1998)
combined fat-and carbohydrate-induced hyperlipaemia Hyperlipoproteinaemia characterised by increased plasma levels of chylomicrons, VLDL, pre-beta-lipoproteins, and triglycerides, and slight rise of cholesterol on a normal diet, with beta-lipoproteins normal; may be accompanied by bouts of abdominal pain, hepatosplenomegaly, susceptibility to atherosclerosis, and abnormal glucose tolerance; probably autosomal recessive inheritance.
Synonym: combined fat-and carbohydrate-induced hyperlipaemia, familial hyperchylomicronaemia with hyperprebetalipoproteinaemia, mixed hyperlipaemia.
(05 Mar 2000)
combined glaucoma Glaucoma with angle-closure and open-angle mechanisms in the same eye.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • convulsive
    °æ·Ã¼ºÀÇ
  • convulsive
    °æ·Ã¼ºÀÇ;¹ßÀÛÀûÀÎ;°æ·ÃÀ» ÀÏÀ¸Å² µíÇÑ
  • insulin
    Àν¶¸°(ÃéÀå È£¸£¸ó,´ç´¢º´ÀÇ Æ¯È¿¾à)
  • insulin shock(coma)
    Àν¶¸°¼îÅ©(Àν¶¸° °úÀ× Åõ¿©·Î ÀϾ´Â ¼îÅ©)
  • combined
    °áÇÕµÈ;ÇÕµ¿ÀÇ;¿¬ÇÕÀÇ;È­ÇÕÇÑ
  • combined arms
    Á¦º´ ¿¬Çպδë(±â°©.º¸º´.Æ÷º´.°øº´.Ç×°øºÎ´ë µîÀ» ÅëÇÕÇÑ ÀÛÀü ºÎ´ë)
  • combined operations (exercises)
    ¿¬ÇÕ ÀÛÀü
  • therapy
    Ä¡·á; ¿ä¹ý
  • Xray therapy
    ¿¢½º¼± ¿ä¹ý
  • cell therapy
    ¼¼Æ÷¿ä¹ý(¾çÀÇ °«³­»õ³¢ÀÇ ¼¼Æ÷¸¦ ÁÖÀÔÇϴ ȸÃá¹ý ('
  • cellar therapy
    =CELL THERAPY
  • deep therapy
    ½ÉºÎ X¼± Ä¡·á(ÁÖ´ë»óÀº ¾Ç¼º Á¾¾ç)
  • electric shock therapy
    (Á¤ÀÇ)Àü±â ¼îÅ©¿ä¹ý
  • electroconvulsive therapy
    =ELECTROSHOCK THERAPY
  • electroshock therapy
    (Á¤ÀÇ)Àü±â ¼îÅ©(Ãæ°Ý)¿ä¹ý
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á